Balchem Valuation

Is BCPC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BCPC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: BCPC ($154.95) is trading above our estimate of fair value ($124.16)

Significantly Below Fair Value: BCPC is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for BCPC?

Other financial metrics that can be useful for relative valuation.

BCPC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue5.7x
Enterprise Value/EBITDA24.8x
PEG Ratio3.2x

Price to Earnings Ratio vs Peers

How does BCPC's PE Ratio compare to its peers?

The above table shows the PE ratio for BCPC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average31.9x
ASH Ashland
31.7x17.6%US$4.9b
FUL H.B. Fuller
28.2x29.8%US$4.5b
NEU NewMarket
15.7xn/aUS$6.0b
ESI Element Solutions
52.1x34.7%US$6.0b
BCPC Balchem
46.1x14.5%US$5.0b

Price-To-Earnings vs Peers: BCPC is expensive based on its Price-To-Earnings Ratio (46.1x) compared to the peer average (31.9x).


Price to Earnings Ratio vs Industry

How does BCPC's PE Ratio compare vs other companies in the US Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a15.4%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a15.4%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: BCPC is expensive based on its Price-To-Earnings Ratio (46.1x) compared to the US Chemicals industry average (22.1x).


Price to Earnings Ratio vs Fair Ratio

What is BCPC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BCPC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio46.1x
Fair PE Ratio18.8x

Price-To-Earnings vs Fair Ratio: BCPC is expensive based on its Price-To-Earnings Ratio (46.1x) compared to the estimated Fair Price-To-Earnings Ratio (18.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BCPC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$154.95
US$154.33
-0.4%
8.9%US$165.00US$135.00n/a3
Mar ’25US$156.93
US$154.33
-1.7%
8.9%US$165.00US$135.00n/a3
Feb ’25US$142.90
US$145.00
+1.5%
4.9%US$150.00US$135.00n/a3
Jan ’25US$148.75
US$145.00
-2.5%
4.9%US$150.00US$135.00n/a3
Dec ’24US$124.94
US$145.00
+16.1%
4.9%US$150.00US$135.00n/a3
Nov ’24US$116.70
US$145.00
+24.3%
4.9%US$150.00US$135.00n/a3
Oct ’24US$124.04
US$157.00
+26.6%
3.9%US$165.00US$150.00n/a3
Sep ’24US$140.59
US$158.33
+12.6%
3.9%US$165.00US$150.00n/a3
Aug ’24US$133.20
US$158.33
+18.9%
3.9%US$165.00US$150.00n/a3
Jul ’24US$134.81
US$153.33
+13.7%
3.1%US$160.00US$150.00n/a3
Jun ’24US$125.37
US$150.00
+19.6%
5.4%US$160.00US$140.00n/a3
May ’24US$131.01
US$150.00
+14.5%
5.4%US$160.00US$140.00n/a3
Apr ’24US$126.48
US$150.00
+18.6%
5.4%US$160.00US$140.00n/a3
Mar ’24US$132.67
US$150.00
+13.1%
5.4%US$160.00US$140.00US$156.933
Feb ’24US$135.72
US$155.67
+14.7%
4.3%US$165.00US$150.00US$142.903
Jan ’24US$122.11
US$155.67
+27.5%
4.3%US$165.00US$150.00US$148.753
Dec ’23US$140.90
US$155.67
+10.5%
4.3%US$165.00US$150.00US$124.943
Nov ’23US$139.30
US$164.33
+18.0%
0.3%US$165.00US$164.00US$116.703
Oct ’23US$121.58
US$164.33
+35.2%
0.3%US$165.00US$164.00US$124.043
Sep ’23US$130.43
US$164.33
+26.0%
0.3%US$165.00US$164.00US$140.593
Aug ’23US$127.86
US$160.33
+25.4%
3.7%US$165.00US$152.00US$133.203
Jul ’23US$130.37
US$160.33
+23.0%
3.7%US$165.00US$152.00US$134.813
Jun ’23US$123.97
US$163.67
+32.0%
5.7%US$175.00US$152.00US$125.373
May ’23US$123.20
US$164.67
+33.7%
5.0%US$175.00US$155.00US$131.013
Apr ’23US$139.82
US$164.67
+17.8%
5.0%US$175.00US$155.00US$126.483
Mar ’23US$136.50
US$169.67
+24.3%
2.7%US$175.00US$164.00US$132.673

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.